Research progress of gene target therapy for refractory epilepsy
Chinese Journal of Contemporary Neurology and Neurosurgery(2014)
Abstract
Nowadays, the strategies of gene therapy for the treatment of refractory epilepsy (RE) mainly include modulating neurotransmitter systems, neuropeptide Y (NPY) and neurotrophic factors. Among them, the hot target spots include γ-aminobutyric acid (GABA) and its receptor, N-methyl-D-aspartate (NMDA) and its receptor, galanin, NPY and neurotrophic factors. This paper reviews the chief research results, and advantages and disadvantages of studies, and provides evidence for the treatment of refractory epilepsy. doi: 10.3969/j.issn.1672-6731.2014.12.004
MoreTranslated text
Key words
Epilepsy,Gene therapy,Gamma-aminobutyric acid,N-methylaspartate,Galanin-like peptide,Neuropeptide Y,Nerve growth factors,Review
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined